Identification of Mycobacterium tuberculosis in Pulmonary and Extrapulmonary Specimens: A Comparative Analysis from Suspected TB Patients

Authors

  • Salma Zeb lady readung hospital
  • Zafar Mehmood Department of Neurology, Medical Teaching Institute, Lady Reading Hospital, Peshawar - Pakistan
  • Anila Basit Department of Pulmonology, Medical Teaching Institute, Lady Reading Hospital, Peshawar – Pakistan
  • Muhammad Zubair Khan Department of Internal Medicine, Medical Teaching Institute, Lady Reading Hospital, Peshawar - Pakistan
  • Izma Khan Department of Internal Medicine, Medical Teaching Institute, Lady Reading Hospital, Peshawar - Pakistan
  • Shakir Ullah Department of Internal Medicine, Medical Teaching Institute, Lady Reading Hospital, Peshawar - Pakistan

Keywords:

Tuberculosis, Pulmonary TB, Extrapulmonary TB, Diagnostic Techniques

Abstract

Background: Tuberculosis (TB) is a deadly disease caused by Mycobacterium tuberculosis (MTB) and continues to pose a significant challenge to public health departments globally. TB infected millions of people annually. Timely and accurate diagnosis is crucial for effective treatment and halting its spread. Timely and accurate diagnosis is crucial for effective treatment and halting its spread. Objective: The current study was undertaken to determine the prevalence of tuberculosis (TB) in clinical samples collected from hospitalized patients who were suspected of having pulmonary tuberculosis (PTB) or extrapulmonary tuberculosis (EPTB). Methodology: The present research was conducted using samples from individuals suspected of having pulmonary and extrapulmonary tuberculosis (TB) who sought care at the Medicine department of Lady Reading Hospital in Peshawar, Pakistan, between January 2021 and December 2021. GeneXpert MTB/RIF testing was applied to all samples received by this department, providing results for both MTB detection and rifampicin resistance. Demographic and clinical data were extracted from the patients' medical records. Results: Among 1170 suspected TB cases, 41.02% tested positive for Mycobacterium tuberculosis, with males comprising 75% of positive cases. The average age was 45.60 years, and the average hospital stay was 12.89 days. Sputum was the most common sample source (73%). Pulmonary TB accounted for 79.16% of cases, with 44% showing concurrent PTB among extrapulmonary TB cases. Chest imaging revealed notable findings, with a "tree-in-bud" appearance significantly associated with pulmonary TB. Conclusion: The epidemiology and characteristics of tuberculosis (TB) among suspected cases. Males were predominantly affected, with 41.02% testing positive for Mycobacterium tuberculosis. Radiological findings, notably the "tree-in-bud" appearance, were significant in diagnosing pulmonary TB.

References

Gopalaswamy R, Dusthackeer VA, Kannayan S, Subbian S. Extrapulmonary tuberculosis—an update on the diagnosis, treatment and drug resistance. J Resp. 2021;1(2):141-64.

Bagcchi S. WHO's global tuberculosis report 2022. Lancet Microbe. 2023;4(1):e20.

Azadi D, Motallebirad T, Ghaffari K, Shojaei H. Mycobacteriosis and tuberculosis: laboratory diagnosis. Open Micro J. 2018;12:41.

Alam M, Shahzad MI, Pervaiz S, Jamil M, Afzal MW, Mushtaq A. Comparison of Induced Sputum with Bronchoalveolar Lavage Samples for Pulmonary Tuberculosis diagnosis in sputum scarce Patients. Pak J Chest Med. 2020;26(3):140–4.

Malik M, Malik MI, Saulat A, Khan JK, Shahzadi N, Ashraf Z. Yield of Xpert MTB/RIF Assay in Extra Pulmonary Specimens of Patients at Tertiary Care Hospital. Pak J Chest Med. 2020;26(1):03–7.

Nguyen TN, Anton-Le Berre V, Bañuls AL, Nguyen TV. Molecular diagnosis of drug-resistant tuberculosis; a literature review. Front Micro. 2019;10:794.

Santiago-García B, Blazquez-Gamero D, Baquero-Artigao F, Ruíz-Contreras J, Bellon JM, Munoz-Fernandez MA, et al. Pediatric extrapulmonary tuberculosis: clinical spectrum, risk factors and diagnostic challenges in a low prevalence region. J Pediatr Infect Dis. 2016;35(11):1175-81.

Naidoo K, Dookie N. Can the GeneXpert MTB/XDR deliver on the promise of expanded, near-patient tuberculosis drug-susceptibility testing? Lancet Infect Dis. 2022;22(4):e121-7.

Raja SK, Ullah R, Shah SW, Ambreen S, Khan H, Habib M. Comparative Sensitivity of Smear Microscopy for AFB Versus Gene Xpert/RIF Assay on Endrobronchial Washings of the Sputum Smear Negative/Sputum Scarce Patients with Suspected Pulmonary Tuberculosis. 2020; Pak J Chest Med. 26(4);201–4.

Khosravi AD, Alavi SM, Hashemzade M, Abasi E, Seghatoleslami S. The relative frequency of Mycobacterium tuberculosis and Mycobacterium avium infections in HIV positive patients, Ahvaz, Iran. Asian Pac J Trop Med. 2012;5(1):71–74. DOI: 10.1016/S1995-7645(11)60249-6.

Seyoum B, Demissie M, Worku A, Bekele S, Aseffa A. Prevalence and Drug Resistance Patterns of Mycobacterium tuberculosis among New Smear Positive Pulmonary Tuberculosis Patients in Eastern Ethiopia. Tuberc Res Treat. 2014:753492. DOI: 10.1155/2014/753492.

Burusie A, Enquesilassie F, Addissie A, Dessalegn B, Lamaro T. Effect of smoking on tuberculosis treatment outcomes: A systematic review and meta-analysis. PLoS One. 2020;15(9):e0239333.

Tran J, Green O, Modahl L. Chest Manifestations of Mycobacterium Tuberculosis Complex-Clinical and Imaging Features. In Seminars in Roentgenology. 2022;57(1):67-74. WB Saunders.

Helke KL, Mankowski JL, Manabe YC. Animal models of cavitation in pulmonary tuberculosis. Tuberculosis. 2006;86(5):337-48.

Rana P, Bhatia A, Saxena AK, Sodhi KS. Imaging of Tuberculosis in Children. Contemp Diagn Radiol. 2021;44(21):1-7.

Downloads

Published

2023-12-03

How to Cite

Zeb, S., Mehmood, Z., Basit, A., Khan, M. Z. ., Khan, I., & Ullah, S. (2023). Identification of Mycobacterium tuberculosis in Pulmonary and Extrapulmonary Specimens: A Comparative Analysis from Suspected TB Patients. Pakistan Journal of Chest Medicine, 29(4), 477–485. Retrieved from http://pjcm.net/index.php/pjcm/article/view/887

Issue

Section

Original Article

Most read articles by the same author(s)

1 2 3 4 > >>